The area above the belly button often provides suitable subcutaneous tissue for injection, particularly in the upper quadrants of the abdomen
It is also known by its generic name, Tirzepatide, a new injectable medication developed by Eli Lilly
The device was worn starting 10 days before baseline measurements were obtained throughout the course of the 32-week period
It also said that it has received multiple reports of adverse events, some requiring hospitalization, that may be related to dosing errors associated with compounded injectable semaglutide products. By the end of February the FDA had received more than 455 reports of adverse events with compounded semaglutide and more than 320 reports of adverse events with compounded tirzepatide
Lara gives you an oral sedative for your comfort
Both medications can cause digestive side effects such as nausea, constipation, diarrhea, vomiting or stomach discomfort